Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

UCHL1is a biomarker of aggressive multiple myeloma required for disease progression

19 Oct 2015

Abstract excerpt

// Sajjad Hussain 1 , Tibor Bedekovics 1 , Marta Chesi 2 , P. Leif Bergsagel 2 , Paul J. Galardy 1, 3 1 Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA 2 Division of Hematology-Oncology, Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ, USA 3 Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN, USA Correspondence to: Paul J. Galardy, e-mail:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26513019
DOI: 10.18632/oncotarget.5727

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

UCHL1is a biomarker of aggressive multiple myeloma required for disease progressionPMID 26513019Read ↗

The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myelomaSemantic proximity Read ↗

The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myelomaSemantic proximity Read ↗

UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progressionSemantic proximity Read ↗

Emerging therapies targeting the ubiquitin proteasome system in cancerSemantic proximity Read ↗

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagySemantic proximity Read ↗

Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1Semantic proximity Read ↗

LAGλ-1: A clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myelomaSemantic proximity Read ↗

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma CellsSemantic proximity Read ↗

USP8 Controls Proteostasis Pathways in B Cells and Multiple MyelomaSemantic proximity Read ↗

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myelomaSemantic proximity Read ↗

Proteasome-associated deubiquitinases and cancerSemantic proximity Read ↗

Mouse models of human multiple myeloma subgroupsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.